SYK vs ZBH
SYK and ZBH side by side — valuation & fundamentals (public data).
Key statistics
| Metric | SYKSTRYKER CORP | ZBHZIMMER BIOMET HOLDINGS, INC. |
|---|---|---|
| Market cap | $130.00B | $18.43B |
| P/E (TTM) | 35.1 | 23.4 |
| P/B | 11.08 | 1.46 |
| P/S | 5.2x | 2.2x |
| Dividend yield | 0.99% | 1.03% |
| Revenue | $25.84B(TTM) | $8.51B(TTM) |
| Revenue growth (YoY) | 11.2% | 7.2% |
| Net income | $3.73B(TTM) | $806.70M(TTM) |
| Earnings growth (YoY) | 8.5% | -22.0% |
| EPS, diluted | $9.65(TTM) | $4.12(TTM) |
| EBIT margin | 19.5% | 13.3% |
| ROE | 27.7% | 5.6% |
| ROIC | 15.1% | 5.0% |
| Piotroski F | 8/9 | 6/9 |
| 1y total return | -9.0% | -0.8% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: SYK vs ZBH
| Metric | SYK | ZBH |
|---|---|---|
| End value | $35.0K | $9.7K |
| Total return | +250.2% | -2.8% |
| CAGR | +12.9% | -0.3% |
| Volatility | 26.5% | 28.4% |
| Sharpe | 0.45 | 0.00 |
| Sortino | 0.64 | 0.00 |
| Max drawdown | -43.8% | -53.5% |
Based on 2600 common trading days, 2016-04-06 → 2026-08-07 · risk-free 3.87% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)